Susan M. O’Gorman, MBBCh; Julianne Clowry, MBBCh; Michael Manley, MSc; et al.
free access
JAMA Dermatol. 2016;152(6):638-644. doi:10.1001/jamadermatol.2015.5436
This clinical trial compares the effectiveness of daylight vs artificial white light with topical methyl 5-aminolevulinic acid photodynamic therapy for actinic keratoses in a cohort of 22 men.
Derek Hsu, BA; Joaquin Brieva, MD; Jonathan I. Silverberg, MD, PhD, MPH
free access
JAMA Dermatol. 2016;152(6):645-654. doi:10.1001/jamadermatol.2015.5240
This study examines the incidence of and risk factors for hospitalization for patients with pemphigus and cost of care.
Kristina J. Liu, MD; Rebecca I. Hartman, MD, MPH; Cara Joyce, PhD; et al.
free access
JAMA Dermatol. 2016;152(6):655-660. doi:10.1001/jamadermatol.2016.0183
This review of 253 referrals from primary care clinicians to dermatologists for acne measures algorithm-based treatment for the elimination of unnecessary dermatology appointments.
April W. Armstrong, MD, MPH; Charles W. Lynde, MD, FRCP; Sandy R. McBride, MBBS, FRCP, MD; et al.
free access
JAMA Dermatol. 2016;152(6):661-669. doi:10.1001/jamadermatol.2016.0269
These 3 randomized clinical trials assess the effect of ixekizumab therapy on work productivity in adults with moderate-to-severe chronic plaque psoriasis.
Nicholas A. Ross, MD; Hye-Jin Chung, MD; Qiaoli Li, PhD; et al.
free access
JAMA Dermatol. 2016;152(6):670-675. doi:10.1001/jamadermatol.2016.0091
This case series of patients with pityriasis rubra pilaris evaluates objective and subjective disease experience metrics from the perspectives of patients and clinicians.
Shirin Bajaj, BA; Michael A. Marchetti, MD; Cristian Navarrete-Dechent, MD; et al.
free access
JAMA Dermatol. 2016;152(6):676-682. doi:10.1001/jamadermatol.2016.0270
In this study, a sample of skin lesions was shown to attendees of a dermoscopy course to determine if diagnostic accuracy for common skin lesions differs between gray-scale and color dermoscopic images.
Silvia Soohyun Song, MD; Alina Goldenberg, MD, MAS; Arisa Ortiz, MD; et al.
free access
JAMA Dermatol. 2016;152(6):683-690. doi:10.1001/jamadermatol.2016.0192
This study reviews the clinical characteristics of nonmelanoma skin cancer with aggressive subclinical extensions (NMSC-ASE) among immunocompetent and various subgroups of immunosuppressed patients and suggests a predictive model for NMSC-ASE lesions.